Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Conference Call March 7, 2024 9:00 AM ET
Company Participants
Scott Gordon - CORE Investor Relations
Rick Eiswirth - President & Chief Executive Officer
Elliot Maltz - Chief Financial Officer
Todd Wood - President, U.S. Operations
Conference Call Participants
Alex Nowak - Craig-Hallum Capital
James Molloy - Alliance Global Partners
Operator
Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences Fourth Quarter and Fiscal Year 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]
Participants on this call are advised that audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately one hour after the end of the call through June 7, 2024.
I would now like to turn the call over to Scott Gordon of CORE IR, the company's Investor Relations firm. Please go ahead sir.
Scott Gordon
Thank you, Scott. Good morning and thank you for participating in today's conference call. Joining me from Alimera's leadership team are Rick Eiswirth, President and Chief Executive Officer; and Elliot Maltz, Chief Financial Officer; and Todd Wood will be joining us President, U.S. Operations in the question-and-answer session today.
During this call management will be making forward-looking statements, including statements that address Alimera's expectations for future performance or operational results, future financial position, outlook and guidance and time line for achieving positive cash flow. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors described in Alimera's most recently filed periodic reports on Form 10-Q, or Form 8-K filed with the SEC today, and Form 10-K to be filed with the SEC from year ended December 31, 2023 as well as Alimera's press release that accompanies this call, particularly the cautionary statements in it.
Today's conference call will include references to adjusted EBITDA, which is a non-GAAP financial measure. Please see the explanatory language and reconciliation table located in Alimera's earnings press release. The content of this call contains time-sensitive information that is accurate only as of today March 7, 2024. Except as required by law, Alimera disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call.